Back to News
Market Impact: 0.05
MapLight Therapeutics to Participate in Upcoming Investor Conference
Source: globenewswire.com
Healthcare & BiotechManagement & Governance
MapLight Therapeutics (Nasdaq: MPLT) announced that members of its management team will participate in an investor conference. The release provides no financial results, clinical updates, guidance, or other material business details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
MPLT0.10
More News
- How Pepsi fell behind in the cola wars—and then lost KFC
- Xencor reports phase 1 data for cancer drug XmAb819
- ‘We like to be first to be second’: How True Religion’s CEO is rebuilding the denim brand for Gen Z and millennials
- Biotech stocks are surging. How investors can play the new drug innovation boom
- UK immigration crackdown threatens £15 billion care sector
- IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER